KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,979 | +27.9% | 15,658 | +3.7% | 0.00% | +100.0% |
| Q2 2023 | $212,622 | +31.4% | 15,101 | +0.4% | 0.00% | 0.0% |
| Q1 2023 | $161,777 | -26.7% | 15,035 | +2.0% | 0.00% | -50.0% |
| Q4 2022 | $220,745 | +16.2% | 14,736 | -0.4% | 0.00% | +100.0% |
| Q3 2022 | $190,000 | +34.8% | 14,790 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $141,000 | -2.1% | 14,581 | +0.7% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | -20.9% | 14,479 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $182,000 | 0.0% | 15,499 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $182,000 | -20.2% | 15,962 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $228,000 | -20.8% | 16,341 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $288,000 | +4.7% | 15,580 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $275,000 | +12.2% | 15,540 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $245,000 | -17.2% | 15,984 | +37.4% | 0.00% | 0.0% |
| Q2 2020 | $296,000 | +131.2% | 11,629 | +40.8% | 0.00% | 0.0% |
| Q1 2020 | $128,000 | +32.0% | 8,259 | -5.5% | 0.00% | – |
| Q4 2019 | $97,000 | +29.3% | 8,737 | -0.8% | 0.00% | – |
| Q3 2019 | $75,000 | -37.5% | 8,810 | -0.7% | 0.00% | – |
| Q2 2019 | $120,000 | -12.4% | 8,871 | +17.3% | 0.00% | -100.0% |
| Q1 2019 | $137,000 | +14.2% | 7,560 | +77.0% | 0.00% | – |
| Q4 2018 | $120,000 | +9.1% | 4,272 | -0.7% | 0.00% | – |
| Q3 2018 | $110,000 | – | 4,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |